Recombinant Human FGF-4 (aa 71-206) Protein Summary
Product Specifications
Ser71-Leu206 with an N-terminal Met
Analysis
Product Datasheets
7460-F4 (with carrier)
7460-F4/CF (carrier free)
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
7460-F4
Formulation | Lyophilized from a 0.2 μm filtered solution in MOPS, Na2SO4 and EDTA with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
7460-F4/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in MOPS, Na2SO4 and EDTA. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: FGF-4
FGF‑4 (fibroblast growth factor‑4), also known as FGF-K or K‑FGF (Kaposi’s sarcoma-associated FGF), is a 25 kDa secreted, heparin‑binding member of the FGF family (1, 2). The human FGF‑4 cDNA encodes 206 amino acids (aa) with a 33 aa signal sequence and a 173 aa mature protein with an FGF homology domain that contains a heparin binding region near the C‑terminus (2). Mature human FGF‑4 (aa 71‑206) shares 91%, 82%, 94% and 91% aa identity with mouse, rat, canine and bovine FGF‑4, respectively. Human FGF‑4 has been shown to exhibit cross species activity. Expression of FGF-4 and its receptors, FGF R1c, 2c, 3c and 4, is spatially and temporally regulated during embryonic development (1, 3). Its expression in the mouse trophoblast inner cell mass promotes expression of FGF R2, and is required for maintenance of the trophectoderm and primitive endoderm (3‑5). Later in mouse development, FGF‑4 works together with FGF‑8 to mediate the activities of the apical ectodermal ridge, which direct the outgrowth and patterning of vertebrate limbs (3, 6‑9). FGF-4 is proposed to play a physiologically relevant role in human embryonic stem cell self-renewal. It promotes stem cell proliferation, but may also aid differentiation depending on context and concentration, and is often included in embryonic stem cell media in vitro (10‑12). A C‑terminally truncated 15 kDa isoform that opposes full‑length FGF‑4 and promotes differentiation is endogenously expressed in human embryonic stem cells. FGF‑4 is mitogenic for fibroblasts and endothelial cells in vitro and has autocrine transforming potential (13). It is a potent angiogenesis promoter in vivo and has been investigated as therapy for coronary artery disease (14).
- Reuss, B. and O. von Bohlen und Halbach (2003) Cell Tiss. Res. 313:139.
- Hebert, J.M. et al. (1990) Dev. Biol. 138:454.
- Niswander, L. and G.R. Martin (1992) Development 114:755.
- Feldman, B. et al. (1995) Science 267:246.
- Goldin, S.N. and V.E. Papaioannou (2003) Genesis 36:40.
- Sun, X. et al. (2002) Nature 418:501.
- Boulet, A.M. et al. (2004) Dev. Biol. 273:361.
- Yu, K and D.M. Ornitz (2008) Development 135:483.
- Mariani, F.V. et al. (2008) Nature 453:401.
- Johannesson, M. et al. (2009) PLoS ONE 4:e4794.
- Kunath, T. et al. (2007) Development 134:2895.
- Mayshar, Y. et al. (2008) Stem Cells 26:767.
- Hajitou, A. et al. (1998) Oncogene 17:2059.
- Flynn, A. and T. O’Brien (2008) IDrugs 11:283.
Citations for Recombinant Human FGF-4 (aa 71-206) Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
2
Citations: Showing 1 - 2
Filter your results:
Filter by:
-
Generation of lung organoids from human pluripotent stem cells in vitro
Authors: AJ Miller, BR Dye, D Ferrer-Tor, DR Hill, AW Overeem, LD Shea, JR Spence
Nat Protoc, 2019-02-01;14(2):518-540.
Species: Human
Sample Types: Whole Tissue
Applications: Bioassay -
Billion-scale production of hepatocyte-like cells from human induced pluripotent stem cells
Authors: T Yamashita, K Takayama, F Sakurai, H Mizuguchi
Biochem. Biophys. Res. Commun., 2018-02-01;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Differentiation, Differentiation
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human FGF-4 (aa 71-206) Protein
There are currently no reviews for this product. Be the first to review Recombinant Human FGF-4 (aa 71-206) Protein and earn rewards!
Have you used Recombinant Human FGF-4 (aa 71-206) Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image